To receive daily emails from Breaking Christian News to your inbox CLICK HERE

"We don't know whether vitamin C will work in humans, but we now have a rational basis for doing a clinical trial. It also helps that we know vitamin C is inexpensive, widely available and very safe to use. At the very least, this work shows us a new mechanism that we can exploit to attack TB." –Dr. William Jacobs, Jr.

(Bronx, NY)—In a striking, unexpected discovery, researchers at Albert Einstein College of Medicine of Yeshiva University have determined that vitamin C kills drug-resistant tuberculosis (TB) bacteria in laboratory culture. The finding suggests that vitamin C added to existing TB drugs could shorten TB therapy, and it highlights a new area for drug design. The study was published today in the online journal Nature Communications.

TB is caused by infection with the bacterium M. tuberculosis. In 2011, TB sickened some 8.7 million people and took some 1.4 million lives, according to the World Health Organization. Infections that fail to respond to TB drugs are a growing problem: About 650,000 people worldwide now have multi-drug-resistant TB (MDR-TB), 9 percent of whom have extensively drug-resistant TB (XDR-TB).TB is especially acute in low and middle income countries, which account for more than 95 percent of TB-related deaths, according to the World Health Organization.

The Einstein discovery arose during research into how TB bacteria become resistant to isoniazid, a potent first-line TB drug. The lead investigator and senior author of the study was William Jacobs, Jr. Ph.D., professor of microbiology and microbiology and of genetics at Einstein. Dr. Jacobs is a Howard Hughes Medical Institute investigator and a recently elected member of the National Academy of Sciences. (Photo by: Shaun W)

Dr. Jacobs and his colleagues observed that isoniazid-resistant TB bacteria were deficient in a molecule called mycothiol.

"We hypothesized that TB bacteria that can't make mycothiol might contain more cysteine, an amino acid," said Dr. Jacobs. "So, we predicted that if we added isoniazid and cysteine to isoniazid-sensitive M. tuberculosis in culture, the bacteria would develop resistance. Instead, we ended up killing off the culture— something totally unexpected."

The Einstein team suspected that cysteine was helping to kill TB bacteria by acting as a "reducing agent" that triggers the production of reactive oxygen species (sometimes called free radicals), which can damage DNA.

"To test this hypothesis, we repeated the experiment using isoniazid and a different reducing agent— vitamin C," said Dr. Jacobs. "The combination of isoniazid and vitamin C sterilized the M. tuberculosis culture. We were then amazed to discover that vitamin C by itself not only sterilized the drug-susceptible TB, but also sterilized MDR-TB and XDR-TB strains."

To justify testing vitamin C in a clinical trial, Dr. Jacobs needed to find the molecular mechanism by which vitamin C exerted its lethal effect. More research produced the answer: Vitamin C induced what is known as a Fenton reaction, causing iron to react with other molecules to create reactive oxygen species that kill the TB bacteria.

"We don't know whether vitamin C will work in humans, but we now have a rational basis for doing a clinical trial," said Dr. Jacobs. "It also helps that we know vitamin C is inexpensive, widely available and very safe to use. At the very least, this work shows us a new mechanism that we can exploit to attack TB."

The paper is titled, "Mycobacterium tuberculosis is extraordinarily sensitive to killing by a vitamin C-induced Fenton reaction." The other contributors are Catherine Vilcheze, Ph.D., Travis Hartman and Brian Weinrick, Ph.D., all at Einstein.

To receive daily emails from Breaking Christian News to your inbox CLICK HERE

Veterans Day is Wednesday. Here's Everyplace Offering Freebies, Discounts to Our Vets

Ancient Evidence Suggests Roman Emperor Sought to Recognize Jesus as God

Charlie Kirk's Family 'Deeply' Disappointed by Tyler Robinson's Trial Delay

Texas Democrats Launch MASSIVE Assault on Second Amendment Just Days after Election Sweep

Gaza-Born DSAer Ahmed Moor Challenges Sen. John Fetterman in PA; Advises Hamas and Palestinian Islamic Jihad Charity, Praised the Oct. 7 Slaughter in Israel

President Trump Chooses Stephen Miller as White House Chief of Staff

SCOTUS: Border Wall Construction Can Resume, Saving Government a Half-Million Dollars a Day

Secretary Hegseth: Impeachment Charges a Stunt 'Driven by Ego and Resentment'

NBC Drops 'National Anthem' from Football Broadcast

Nvidia CEO Jensen Huang Apologizes as Firm Probes Affair with Alleged Chinese Spy

Prayer Alert: Hackers Target America's Freezers; A Threat to Food and Medicine

After the Midterms, What's Next? History Tells Us

'Missing' Memory Card Flips Georgia House Race for GOP

US Supreme Court Likely to Rule in Favor of Catholic Preschool in Religious Liberty Case, Experts Say

Gratitude Changes Your Brain. Here's How

Allie Beth Stuckey Launches a New Space for Christian Women and Moms

2 in 3 Churchgoers Fail Bible Literacy Quiz

This Hail Mary Move Could Save the Supreme Court from the Democrats

Another Florida WIN: CAIR-Florida Shutters Operations as Judge Leaves Terror Designation Intact

Modern-Day Sodom and Gomorrah: California City Moves to Legally Recognize Polyamorous Partnerships

Steve Shultz, Managing Editor
Founder and Owner

Aimee Herd, Editor